162 related articles for article (PubMed ID: 19132131)
1. Peroxisome proliferator-activated receptors and hepatitis C virus-induced insulin resistance.
Negro F
PPAR Res; 2009; 2009():483485. PubMed ID: 19132131
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection.
de Gottardi A; Pazienza V; Pugnale P; Bruttin F; Rubbia-Brandt L; Juge-Aubry CE; Meier CA; Hadengue A; Negro F
Aliment Pharmacol Ther; 2006 Jan; 23(1):107-14. PubMed ID: 16393287
[TBL] [Abstract][Full Text] [Related]
3. Transforming Growth Factor β Acts as a Regulatory Molecule for Lipogenic Pathways among Hepatitis C Virus Genotype-Specific Infections.
Patra T; Sasaki R; Meyer K; Ray RB; Ray R
J Virol; 2019 Sep; 93(18):. PubMed ID: 31243135
[TBL] [Abstract][Full Text] [Related]
4. The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms.
Pazienza V; Clément S; Pugnale P; Conzelman S; Foti M; Mangia A; Negro F
Hepatology; 2007 May; 45(5):1164-71. PubMed ID: 17465001
[TBL] [Abstract][Full Text] [Related]
5. The metabolic regulator PGC-1α links hepatitis C virus infection to hepatic insulin resistance.
Shlomai A; Rechtman MM; Burdelova EO; Zilberberg A; Hoffman S; Solar I; Fishman S; Halpern Z; Sklan EH
J Hepatol; 2012 Oct; 57(4):867-73. PubMed ID: 22732512
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of phosphoenolpyruvate carboxykinase cytoplasmic isoform by hepatitis B virus X protein affects hepatitis B virus replication.
Tang X; Yan L; Li H; Du L; Shi Y; Huang F; Tang H
J Med Virol; 2019 Feb; 91(2):258-264. PubMed ID: 30168585
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus core protein genotype 3a increases SOCS-7 expression through PPAR-{gamma} in Huh-7 cells.
Pazienza V; Vinciguerra M; Andriulli A; Mangia A
J Gen Virol; 2010 Jul; 91(Pt 7):1678-86. PubMed ID: 20357037
[TBL] [Abstract][Full Text] [Related]
8. Effect of Peroxisome Proliferator-Activated Receptor-γ Coactivator-1 Alpha Variants on Spontaneous Clearance and Fibrosis Progression during Hepatitis C Virus Infection in Moroccan Patients.
ElFihry R; Elmessaoudi-Idrissi M; Jadid FZ; Zaidane I; Chihab H; Tahiri M; Kabine M; Badre W; Chemin I; Marchio A; Pineau P; Ezzikouri S; Benjelloun S
Virol Sin; 2020 Oct; 35(5):566-574. PubMed ID: 32297157
[TBL] [Abstract][Full Text] [Related]
9. Branched-chain amino acids and pigment epithelium-derived factor: novel therapeutic agents for hepatitis c virus-associated insulin resistance.
Kawaguchi T; Yamagishi S; Sata M
Curr Med Chem; 2009; 16(36):4843-57. PubMed ID: 19929783
[TBL] [Abstract][Full Text] [Related]
10. Aleglitazar, a dual peroxisome proliferator-activated receptor-α and -γ agonist, protects cardiomyocytes against the adverse effects of hyperglycaemia.
Chen Y; Chen H; Birnbaum Y; Nanhwan MK; Bajaj M; Ye Y; Qian J
Diab Vasc Dis Res; 2017 Mar; 14(2):152-162. PubMed ID: 28111985
[TBL] [Abstract][Full Text] [Related]
11. [Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus].
Fu M; Chen H; Li X; Li J; Wu B; Cheng L; Cai M; Fu Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):234-8. PubMed ID: 12048686
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].
Hui JM; Sud A; Farrell GC; Bandara P; Byth K; Kench JG; McCaughan GW; George J
Gastroenterology; 2003 Dec; 125(6):1695-704. PubMed ID: 14724822
[TBL] [Abstract][Full Text] [Related]
13. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-106b induces mitochondrial dysfunction and insulin resistance in C2C12 myotubes by targeting mitofusin-2.
Zhang Y; Yang L; Gao YF; Fan ZM; Cai XY; Liu MY; Guo XR; Gao CL; Xia ZK
Mol Cell Endocrinol; 2013 Dec; 381(1-2):230-40. PubMed ID: 23954742
[TBL] [Abstract][Full Text] [Related]
15. Potential for peroxisome proliferator-activated receptor-gamma agonists in progression: beyond metabolism.
Fogo AB
Curr Opin Nephrol Hypertens; 2008 May; 17(3):282-5. PubMed ID: 18408479
[TBL] [Abstract][Full Text] [Related]
16. Single gene contributions: genetic variants of peroxisome proliferator-activated receptor (isoforms alpha, beta/delta and gamma) and mechanisms of dyslipidemias.
Yong EL; Li J; Liu MH
Curr Opin Lipidol; 2008 Apr; 19(2):106-12. PubMed ID: 18388689
[TBL] [Abstract][Full Text] [Related]
17. PHD3 regulates glucose metabolism by suppressing stress-induced signalling and optimising gluconeogenesis and insulin signalling in hepatocytes.
Yano H; Sakai M; Matsukawa T; Yagi T; Naganuma T; Mitsushima M; Iida S; Inaba Y; Inoue H; Unoki-Kubota H; Kaburagi Y; Asahara SI; Kido Y; Minami S; Kasuga M; Matsumoto M
Sci Rep; 2018 Sep; 8(1):14290. PubMed ID: 30250231
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of the dual peroxisome proliferator activated receptor (PPAR)α/γ agonist aleglitazar in attenuating TNF-α-mediated inflammation and insulin resistance in human adipocytes.
Massaro M; Scoditti E; Pellegrino M; Carluccio MA; Calabriso N; Wabitsch M; Storelli C; Wright M; De Caterina R
Pharmacol Res; 2016 May; 107():125-136. PubMed ID: 26976796
[TBL] [Abstract][Full Text] [Related]
19. [The role of peroxisome proliferator-activated receptors γ (PPARγ) in obesity and insulin resistance].
Chmielewska-Kassassir M; Woźniak LA; Ogrodniczek P; Wójcik M
Postepy Hig Med Dosw (Online); 2013 Dec; 67():1283-99. PubMed ID: 24379269
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus dysregulates glucose homeostasis by a dual mechanism involving induction of PGC1α and dephosphorylation of FoxO1.
Bernsmeier C; Calabrese D; Heim MH; Duong HT
J Viral Hepat; 2014 Jan; 21(1):9-18. PubMed ID: 24329853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
